Once stimulated by TGFβ, CAFs are able to release cytokines and chemokines that attract to the site of tumor lesion immune cells such as neutrophils, macrophages, lymphocytes and natural killer (NK) cells, inducing the reparative inflammatory response that promotes cancer progression (68). The gene discussed is TGFB1; the disease is cancer.